Vaccine For Mold

[Guest guest]

Before you get your hopes up, you should realize that the vaccine has only been

used on mice, so far, as of December 2006. The authors have not published any

new developments on the vaccine since then (I Googled it). I will soon post a

long research article, by the same researchers, (free on the internet) of an

earlier published report on this vaccine. The full research article of the below

abstract, costs $70 (which I don't have). I will post the link to the below

abstract, at the end of the abstract.

Its highly unlikely that any vaccine would be of any use to any of us, who

already suffer from toxic mold reactions. But, it could change the world, like

the polio vaccine did, once OUR EPIDEMIC is acknowledged by the world.

Joe

......................................................................

Opportunistic fungi and fungal infections: the challenge of a single, general

antifungal vaccine

Authors: Cassone, ; Torosantucci, Antonella

Source: Expert Review of Vaccines, Volume 5, Number 6, December 2006 , pp.

859-867(9)

Abstract:

A vaccine made up by an algal â-glucan (laminarin), conjugated with a protein

component, protects against infections by different fungi and induces antibodies

capable of inhibiting fungal growth. Although taking a premium on a common

molecular theme, this remains a sort of `cross-kingdom' vaccine because the

immunizing antigen and the vaccination target belong to organisms from two

different kingdoms and this is certainly the first case in the field of human

vaccines. Thus, it is possible to convey in a single immunological tool the

potential to protect against multiple infections, in theory all those caused by

â-glucan-expressing fungi. The generation of antibodies with the potential to

directly inhibit the growth of, or kill the fungal cells also opens an exciting

perspective for both active and passive vaccination in immunocompromised

subjects.

Keywords: antibodies; antifungal therapy; â-glucan; passive vaccination;

prevention; antibodies; vaccines

Document Type: Research article

DOI: 10.1586/14760584.5.6.859

Click this Link:

http://tinyurl.com/6ppzmg